FR2358384B1 - - Google Patents

Info

Publication number
FR2358384B1
FR2358384B1 FR7721533A FR7721533A FR2358384B1 FR 2358384 B1 FR2358384 B1 FR 2358384B1 FR 7721533 A FR7721533 A FR 7721533A FR 7721533 A FR7721533 A FR 7721533A FR 2358384 B1 FR2358384 B1 FR 2358384B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7721533A
Other languages
French (fr)
Other versions
FR2358384A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of FR2358384A1 publication Critical patent/FR2358384A1/fr
Application granted granted Critical
Publication of FR2358384B1 publication Critical patent/FR2358384B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7721533A 1976-07-12 1977-07-12 Peptides psychopharmacologiquement actifs et derives de ces peptides Granted FR2358384A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7607684A NL7607684A (nl) 1976-07-12 1976-07-12 Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.

Publications (2)

Publication Number Publication Date
FR2358384A1 FR2358384A1 (fr) 1978-02-10
FR2358384B1 true FR2358384B1 (Direct) 1980-02-01

Family

ID=19826579

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7721533A Granted FR2358384A1 (fr) 1976-07-12 1977-07-12 Peptides psychopharmacologiquement actifs et derives de ces peptides

Country Status (18)

Country Link
US (1) US4104371A (Direct)
JP (1) JPS5323938A (Direct)
AU (1) AU504317B2 (Direct)
BE (1) BE856696A (Direct)
CA (1) CA1100947A (Direct)
CH (1) CH636598A5 (Direct)
DE (1) DE2731308A1 (Direct)
DK (1) DK149112B (Direct)
ES (1) ES460620A1 (Direct)
FI (1) FI67366C (Direct)
FR (1) FR2358384A1 (Direct)
GB (1) GB1557076A (Direct)
HU (1) HU181843B (Direct)
IE (1) IE45607B1 (Direct)
LU (1) LU77724A1 (Direct)
NL (1) NL7607684A (Direct)
SE (1) SE442205B (Direct)
ZA (1) ZA773951B (Direct)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2491922A1 (fr) * 1980-10-14 1982-04-16 Roussel Uclaf Nouveaux hexapeptides, procede pour leur preparation et application comme medicaments
NL8101724A (nl) * 1981-04-08 1982-11-01 Akzo Nv Peptiden met zenuw-regenererende eigenschappen.
US4500713A (en) * 1982-09-23 1985-02-19 Usv Pharmaceutical Corporation Therapeutic dipeptides
IE56254B1 (en) * 1982-11-10 1991-06-05 Akzo Nv Peptides
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
JPS6272254U (Direct) * 1985-10-26 1987-05-08
JPS6272255U (Direct) * 1985-10-26 1987-05-08
GB2217319A (en) * 1988-04-19 1989-10-25 Synpharm Ltd Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi
IE912091A1 (en) * 1990-07-18 1992-01-29 Akzo Nv Use of a centrally acting atch analog in the manufacture of a¹medicament
US6261794B1 (en) * 1999-10-14 2001-07-17 Saint Louis University Methods for identifying inhibitors of methionine aminopeptidases
US20020182701A1 (en) * 2001-08-30 2002-12-05 Saint Louis University Dominant negative variants of methionine aminopeptidase 2 (MetAP2) and clinical uses thereof
US20130059914A1 (en) 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
MX2024003466A (es) 2021-09-29 2024-06-04 Ensysce Biosciences Inc Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795788A (nl) * 1972-02-22 1973-08-22 Akzo Nv Werkwijze ter bereiding van peptiden en peptide-derivaten en de toepassing hiervan
US3856770A (en) * 1972-03-08 1974-12-24 Akzona Inc Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175618C (nl) * 1972-07-15 1984-12-03 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.

Also Published As

Publication number Publication date
FI67366B (fi) 1984-11-30
NL7607684A (nl) 1978-01-16
JPS5323938A (en) 1978-03-06
DK314177A (da) 1978-01-13
SE7708036L (sv) 1978-01-13
LU77724A1 (Direct) 1977-10-07
SE442205B (sv) 1985-12-09
FI772156A7 (Direct) 1978-01-13
US4104371A (en) 1978-08-01
HU181843B (en) 1983-11-28
ZA773951B (en) 1978-05-30
GB1557076A (en) 1979-12-05
CH636598A5 (de) 1983-06-15
IE45607B1 (en) 1982-10-06
IE45607L (en) 1978-01-12
FI67366C (fi) 1985-03-11
CA1100947A (en) 1981-05-12
AU504317B2 (en) 1979-10-11
ES460620A1 (es) 1978-05-01
DE2731308A1 (de) 1978-01-19
AU2684477A (en) 1979-01-11
DK149112B (da) 1986-01-27
FR2358384A1 (fr) 1978-02-10
BE856696A (fr) 1978-01-11

Similar Documents

Publication Publication Date Title
FR2358384B1 (Direct)
JPS566747B2 (Direct)
JPS5358661U (Direct)
JPS5736597Y2 (Direct)
JPS5612135Y2 (Direct)
JPS5360689U (Direct)
CS175343B1 (Direct)
JPS5372480U (Direct)
JPS5367159U (Direct)
CS178499B1 (Direct)
JPS5389759U (Direct)
CS175501B1 (Direct)
CS175521B1 (Direct)
CS176346B1 (Direct)
JPS5333217U (Direct)
JPS52164642U (Direct)
IN144700B (Direct)
CS177440B1 (Direct)
CS177787B1 (Direct)
CS178389B1 (Direct)
BE851241A (Direct)
DD124816A1 (Direct)
DD127075A1 (Direct)
DD123670A1 (Direct)
DD126766A1 (Direct)

Legal Events

Date Code Title Description
ST Notification of lapse